Showing results (51-60 of 84) with videos related to
Sort By:
Pageof 9
Journal of Lower Genital Tract Disease|May 8, 2015
Conservative management of positive resection margins after loop electrosurgical excision procedureT A Dinh, M N Garcia, I M Waag, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group studyRachelle Lanciano, Alison Calkins, Brian N Bundy, et al.Gynecologic Oncology|March 3, 2009
A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancerEdwin A Alvarez, Aaron H Wolfson, J Matt Pearson, et al.Gynecologic Oncology|April 9, 2011
A Phase I Study using low-dose fractionated whole abdominal radiotherapy as a chemopotentiator to full-dose cisplatin for optimally debulked stage III/IV carcinoma of the endometriumDené C Wrenn, Kunal Saigal, Joseph A Lucci, et al.Lymphokine and Cytokine Research|June 1, 1991
Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancerF Cappuccini, R S Yamamoto, P J DiSaia, et al.Frontiers in Oncology|July 11, 2022
AHCC® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus InfectionsJudith A Smith, Anjali A Gaikwad, Lata Mathew, et al.Gynecologic Oncology|November 27, 2007
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancerGillian Thomas, Shamshad Ali, Frank J P Hoebers, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patientsT Gatanaga, C D Hwang, W Kohr, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1991
Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar ratsW E Carson, J G Jakowatz, R Yamamoto, et al.Frontiers in Oncology|April 6, 2019
From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus InfectionsJudith A Smith, Lata Mathew, Anjali Gaikwad, et al.Pageof 9